Answers are grounded in this paper and cite their sources.
These results suggest the presence of multiple neurocognitive subgroups in non-psychotic MDD with unique profiles, one of which exhibits deficits comparable to those of schizophrenia. The results of the present study may help guide future efforts to target these disabling symptoms using different treatments.
No takes yet. Share an insight, caveat, or question.
Pu et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: